Platform
Features
Pricing
0 followers
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Employees
Links
Full screen
Niels C. Riedemann
View all
7 people · 0 jobs
5 people · 0 jobs
4 people · 0 jobs
3 people · 0 jobs
HQ
1 position, 0 job posts
BioNTech
32 followers
Tango Therapeutics
3 followers
Cellares
4 followers
Sanofi
279 followers
Gilead Sciences
158 followers
Regeneron
124 followers
Illumina
78 followers
Agilent Technologies
Lonza
66 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
44 followers
Explore companies